HC
BIIB icon

Hara Capital’s Biogen BIIB Stock Holding History

Hara Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-84
Closed -$16.1K – 305
2026
Q1 		$15.4K Hold
84
– – 0.01% 244
2025
Q4 		$14.8K Hold
84
– – 0.01% 236
2025
Q3 		$11.8K Hold
84
– – 0.01% 237
2025
Q2 		$10.6K Hold
84
– – 0.01% 269
2025
Q1 		$11.5K Hold
84
– – 0.01% 239
2024
Q4 		$12.8K Sell
84
-1,090
-93% -$184K 0.01% 239
2024
Q3 		$228K Hold
1,174
– – 0.14% 114
2024
Q2 		$272K Hold
1,174
– – 0.17% 113
2024
Q1 		$253K Hold
1,174
– – 0.15% 116
2023
Q4 		$304K Buy
+1,174
New +$288K 0.21% 97

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hara Capital's BIIB Position: Q2 2026 in Review

Hara Capital sold out of Biogen (BIIB) in Q2 2026, closing a stake of 84 shares — an estimated $16.1K sold.

Hara Capital first reported a position in BIIB in Q4 2023 and held it in 10 quarters. The position peaked at $304K in Q4 2023. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Hara Capital reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
  • Hara Capital sold 84 Biogen shares in Q2 2026, an estimated $16.1K.
  • Hara Capital first reported a position in Biogen in Q4 2023 and held it in 10 quarters.
  • Hara Capital's Biogen position peaked at $304K in Q4 2023.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Hara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.